...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with
【24h】

Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with

机译:新的4-(1-哌嗪基)香豆素衍生物的合成及其体外抗血小板活性。两种最有效化合物对人血小板磷酸二酯酶3的抑制特性以及与它们的相互作用的分子模型研究

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis and in vitro antiplatelet activity significant data of coumarin derivatives 5i-x and quinolin-2(1H)-one derivatives 22a,b, as well as the corresponding structure-activity relationships are described. The recently reported 8-methyl-4-(1-piperazinyl)-7-(3-pyridylmethoxy)coumarin 5f and its potent 7-(2-morpholinoethoxy)-substituted new analogue 5u were notably more effective inhibitors of pure human platelet PDE3 than milrinone and cilostazol: these data were related, through a molecular modeling study, with the molecular interactions of the four compounds with the human PDE3A catalytic site.
机译:描述了香豆素衍生物5i-x和喹啉-2(1H)-one衍生物22a,b的合成和体外抗血小板活性的重要数据,以及相应的结构活性关系。最近报道的8-甲基-4-(1-哌嗪基)-7-(3-吡啶甲氧基)香豆素5f及其有效的7-(2-吗啉代乙氧基)取代的新类似物5u比纯人血小板PDE3更有效米力农和西洛他唑:这些数据通过分子建模研究与这四种化合物与人PDE3A催化位点的分子相互作用有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号